Cristália, one of the largest pharmaceutical companies in Brazil, launched LUNAH, a preservative-free artificial tears, through its ophthalmology division Latinofarma.

Announced in an online event for 2,000+ physicians, LUNAH was launched in the brazilian market in two concentrations of hyaluronic acid, bringing relevant benefits in its formulation.

LUNAH is the company’s first preservative-free artificial tear, and is the result of a partnership between the laboratory and NEMERA, the world leader in the development and production of drug delivery devices for pharmaceutical industries.

The product reinforces Cristália’s commitment to innovation and the development of products that contribute to an improvement in people’s quality of life.

“Lunah was developed with science and technique, focusing on the quality of hyaluronic acid, from the source of the polymer, to ideal viscosity and molecular weight, one of the most important attributes for the treatment of patients with dry eye. Delivered to the consumer in Novelia®, a safe and easy to use multi-dose bottle, Lunah unites technology, quality, innovation and a good cost, democratizing the use of preservative-free eye drops in the Brazilian market”, says Ricardo Pacheco, Chairman at Cristália.